Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity

Abstract

Objective:

The aim of this study was to assess the genetic effects of the vascular endothelial growth factor (VEGF) pathway on retinopathy of prematurity (ROP).

Study Design:

A prospective study from a tertiary center that enrolled 204 Japanese infants (<35 weeks of gestational age (GA)) having no anomalies. ROP developed in 127, but not in 77 infants. The relative severity was defined as non-severe, moderate and severe ROP for GA, based on the staging criteria. VEGF (g.−634G>C, g.+13553C>T) and VEGF-receptor (KDR g.+4422(AC)11 to 14, Flt-1 c.+6724(TG)13 to 23) gene polymorphisms and clinical variables were assessed by uni/multivariate analyses.

Result:

The frequency of polymorphisms did not differ between ROP and non-ROP patients. The TT genotype of g.+13553 showed a higher odds ratio for non-severe ROP than CC genotype (P=0.006). Multivariate analyses indicated that low birth weight, blood transfusion and respiratory distress syndrome, but not polymorphisms, were the risk factors of advanced ROP (stage 3).

Conclusion:

A genotype of the VEGF pathway weakly affects the severity of ROP compared with other clinical factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Chen J, Smith LE . Retinopathy of prematurity. Angiogenesis 2007; 10: 133–140.

    Article  Google Scholar 

  2. Errera FI, Canani LH, Silva ME, Yeh E, Takahashi W, Santos KG et al. Functional vascular endothelial growth factor -634G&gt;C SNP is associated with proliferative diabetic retinopathy: a case-control study in a Brazilian population of European ancestry. Diabetes Care 2007; 30: 275–279.

    Article  CAS  Google Scholar 

  3. Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 2008; 145: 1045–1051.

    Article  CAS  Google Scholar 

  4. Cooke RW, Drury JA, Mountford R, Clark D . Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 2004; 45: 1712–1715.

    Article  Google Scholar 

  5. Vannay A, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A et al. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 2005; 57: 396–398.

    Article  CAS  Google Scholar 

  6. Dunai G, Vásárhelyi B, Szabó M, Hajdú J, Mészáros G, Tulassay T et al. Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 2008; 33: 501–505.

    Article  CAS  Google Scholar 

  7. Shastry BS, Qu X . Lack of association of the VEGF gene promoter (-634 G → C and -460 C → T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 741–743.

    Article  CAS  Google Scholar 

  8. Arrøe M, Peitersen B . Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr 1994; 83: 501–505.

    Article  Google Scholar 

  9. Karna P, Muttineni J, Angell L, Karmaus W . Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 2005; 5: 18–25.

    Article  Google Scholar 

  10. Zaw W, Gagnon R, Silva O . The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics 2003; 111: 1273–1277.

    Article  Google Scholar 

  11. Yang MB, Donovan EF, Wagge JR . Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity. J AAPOS 2006; 10: 253–261.

    Article  Google Scholar 

  12. Akkoyun I, Oto S, Yilmaz G, Gurakan B, Tarcan A, Anuk D et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10: 449–453.

    Article  Google Scholar 

  13. Prepared by an International Committee. An international classification of retinopathy of prematurity. Br J Ophthalmol 1984; 68: 690–697.

    Article  Google Scholar 

  14. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E . A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443–448.

    Article  CAS  Google Scholar 

  15. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki Disease. Pediatr Res 2004; 56: 953–959.

    Article  CAS  Google Scholar 

  16. Parry RG, Gillespie KM, Clark AG, Mathieson PW . Dinucleotide repeat polymorphisms within the Flt-1 gene in minimal change nephropathy. Eur J Immunogenet 1999; 26: 321–323.

    Article  CAS  Google Scholar 

  17. Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietzyk JJ . The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1467–1475.

    Article  CAS  Google Scholar 

  18. Mandal K, Drury JA, Clark DI . An unusual case of retinopathy of prematurity. J Perinatol 2007; 27: 315–316.

    Article  CAS  Google Scholar 

  19. Pieh C, Agostini H, Buschbeck C, Krüger M, Schulte-Mönting J, Zirrgiebel U et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol 2008; 92: 689–693.

    Article  CAS  Google Scholar 

  20. Madan A, Penn JS . Animal models of oxygen-induced retinopathy. Front Biosci 2003; 8: d1030–d1043.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Naoko Kinukawa (Department of Medical Informatics, Kyushu University Hospital, Fukuoka, Japan) and Dr Kazuo Sato (Division of Pediatrics, Kyushu National Medical Center, Fukuoka, Japan) for the statistical assistance and helpful discussion. This research was supported by a Grant-in-Aid for Scientific Research to Hikino S, Takahata Y and Ohga S from the Ministry of Education, Science, Sports and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Ohga.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kusuda, T., Hikino, S., Ohga, S. et al. Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity. J Perinatol 31, 246–250 (2011). https://doi.org/10.1038/jp.2010.111

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.111

Keywords

This article is cited by

Search

Quick links